StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Core structure exploration tiers

Rule-based Catalog Exploration Score from SMILES similarity, approved/clinical tags, family network size, and SAR metadata. It does not predict efficacy, safety, or development success.

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Core 후보 44파생 후보 15439 패밀리

MedMedium exploration priority2

Upper-mid Exploration Score percentile (X-A bin)

High exploration priority2DStructureClassExploration ScoreFactors
Med
MMAE
MMAE (auristatin) payload family · Payload
ADC payload66패밀리 core · Payload core · SMILES 확보
Med
SG3199
PBD dimer ADC payload family · Payload
ADC payload65패밀리 core · Payload core · SMILES 확보
MedMMAE

MMAE (auristatin) payload family · Payload · ADC payload

패밀리 core · Payload core · SMILES 확보

PBD dimer ADC payload family · Payload · ADC payload

패밀리 core · Payload core · SMILES 확보

MedMedium exploration priority2

Mid-pool Exploration Score (X-B bin)

High exploration priority2DStructureClassExploration ScoreFactors
Med
Duocarmycin SA
Duocarmycin CPI ADC payload series · Payload
ADC payload63패밀리 core · Payload core · SMILES 확보
Med
MMAF
MMAE (auristatin) payload family · Payload
ADC payload44Payload core · SMILES 확보

Duocarmycin CPI ADC payload series · Payload · ADC payload

패밀리 core · Payload core · SMILES 확보

MedMMAF

MMAE (auristatin) payload family · Payload · ADC payload

Payload core · SMILES 확보

LowLow exploration priority3

Lower Exploration Score — still listed for inspection (X-C bin)

High exploration priority2DStructureClassExploration ScoreFactors
Low
Tesirine
PBD dimer ADC payload family · Payload
ADC payload43Payload core · SMILES 확보
Low
Seco-duocarmycin
Duocarmycin CPI ADC payload series · Payload
ADC payload41Payload core · SMILES 확보
Low
Val-Cit
MMAE (auristatin) payload family · Linker
ADC payload36Linker hub · SMILES 확보

PBD dimer ADC payload family · Payload · ADC payload

Payload core · SMILES 확보

Duocarmycin CPI ADC payload series · Payload · ADC payload

Payload core · SMILES 확보

MMAE (auristatin) payload family · Linker · ADC payload

Linker hub · SMILES 확보

Actual weights, formula and input limits

Exploration score method

StructureMoa ranks are a rule-based Exploration Score. An LLM does not predict activity or efficacy. Role, SMILES, and relation signals inside each family are summed and cut into High / Medium / Low exploration priority.

Core tab

  • scaffold / payload / linker role weights
  • family center-compound bonus
  • SMILES source (db · known · pubchem · inherited)
  • relation-edge count and derived-child count

Derivative tab

  • drug / derivative / adc candidates
  • similarity to family center via Morgan fingerprint, radius 2, 2048 bits, Tanimoto
  • Approval, clinical and lead tag bonuses have been removed.

Explore tab

  • sparse SAR, cross-scaffold pairs, expansion leaves
  • weakly linked nodes and catalog-coverage gaps
  • relation graph + stored Morgan fingerprints
  • category filters

Exploration-priority bins

  • High (X-S): top ~12%
  • Medium (X-A/X-B): ~12–62%
  • Low (X-C): remainder (pools under 5 compounds stay Medium)

Internal exploration metric based on catalog and structural signals. Not a prediction of efficacy, safety, potency, or development success.

Full methodology

평가 시각: 2026. 10. 28. 오후 9:49:28 · 캐시 5분 · 전체 패밀리